The battle against nasal infections goes into overdrive this week, with the release of the long-awaited Israeli-invented nasal spray.
The over-the-counter spray NOWONDER™ (formerly called Enovid – also branded in some countries as VirX) was developed by the joint Israel-Canada biotech startup SaNOtize established by Dr. Gilly Regev and Dr. Chris Miller.
NOWONDER™ Nitric Oxide Nasal Spray (NONS) blocks the entry of invaders and halts replication within the nasal cavity. This rapidly reduces the total load which is linked to the level of infectivity. It can prevent transmission and lower the severity of infection.
Dr. Regev is an experienced biotech executive with hands-on experience in drug development and biochemistry R&D with 12 years’ work in the field of nitric oxide. Dr. Miller is a pioneer in nitric oxide technology and therapeutic research with 20 years of expertise in clinical trials.
The special features of nitric oxide (NO) form the basis of the innovative products that SaNOtize has developed to treat a wide range of previously difficult or untreatable medical problems.
Dr. Regev called Enovid “a hand sanitizer equivalent for the nose.” It creates a chemical barrier of nitric oxide, which is known for its antimicrobial qualities. As well, it forms a physical barrier in the nasal passages to stop microbes from finding a surface to penetrate. For several years, the scientists at SaNOtize were conducting highly advanced research into the potential of nitric oxide to act as a unique treatment for against nasal infections.
Enovid is Proven in the Lab
SaNOtize has completed several tests for final approval, including a randomized, double-blind, placebo-controlled trial. The trial reported a more than 95% reduction in infection in 24 hours, and more than 99% within 72 hours. A similar study in Canada of healthcare workers and other individuals at risk of infection showed that not one person in the treated group was infected.
How does Enovid/NOWONDER™ work?
“Our novel formulation of nitric oxide for use in humans is designed to kill invaders in the upper airways, preventing them from incubating and spreading to the lungs. The pharmacology, toxicity, and safety data for use in humans has been well-established for decades,” says Dr. Chris Miller, Chief Science Officer and co-founder of SaNOtize. “Our innovative product design also allows the treatment to be self-administered effectively and affordably.”
Where can I buy NOWONDER™?
NOWONDER™ is available right now – Buy NOWONDER™ here
